| Schedule of Computation of Basic and Diluted Net Loss Per Share |
The following table provides the computation of basic and diluted net loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
(in thousands, except per share data) |
| Numerator–basic: |
|
|
|
|
|
|
|
| Net loss attributable to Class A common stockholders–basic |
$ |
(13,296) |
|
|
$ |
(11,173) |
|
|
$ |
(32,311) |
|
|
$ |
(176,100) |
|
| Numerator–diluted: |
|
|
|
|
|
|
|
| Net loss attributable to Class A common stockholders–basic |
$ |
(13,296) |
|
|
$ |
(11,173) |
|
|
$ |
(32,311) |
|
|
$ |
(176,100) |
|
| Effective of dilutive securities: |
|
|
|
|
|
|
|
| Shares of Class V common stock |
(23,993) |
|
|
(54,156) |
|
|
(85,008) |
|
|
(853,125) |
|
| Net loss attributable to Class A common stockholders–diluted |
$ |
(37,289) |
|
|
$ |
(65,329) |
|
|
$ |
(117,319) |
|
|
$ |
(1,029,225) |
|
| Denominator–basic: |
|
|
|
|
|
|
|
| Weighted average Class A common shares outstanding–basic |
114,198 |
|
|
41,579 |
|
|
88,010 |
|
|
41,579 |
|
| Net loss per share attributable to Class A common stockholders–basic |
$ |
(0.12) |
|
|
$ |
(0.27) |
|
|
$ |
(0.37) |
|
|
$ |
(4.24) |
|
| Denominator–diluted: |
|
|
|
|
|
|
|
| Weighted average Class A common shares outstanding–basic |
114,198 |
|
|
41,579 |
|
|
88,010 |
|
|
41,579 |
|
| Weighted average effect of dilutive securities: |
|
|
|
|
|
|
|
| Shares of Class V common stock |
198,481 |
|
|
201,457 |
|
|
200,369 |
|
|
199,684 |
|
| Weighted average shares outstanding–diluted |
312,679 |
|
|
243,036 |
|
|
288,379 |
|
|
241,263 |
|
| Net loss per share attributable to Class A common stockholders–diluted |
$ |
(0.12) |
|
|
$ |
(0.27) |
|
|
$ |
(0.41) |
|
|
$ |
(4.27) |
|
|
| Schedule of Potentially Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share |
The following table presents potentially dilutive securities excluded from the computation of diluted net loss per share for the periods presented because their effect would have been anti-dilutive.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
(in thousands) |
Stock warrants (1)
|
81,938 |
|
|
10,819 |
|
|
81,938 |
|
|
10,819 |
|
Stock options (1)
|
5,867 |
|
|
2,134 |
|
|
5,867 |
|
|
2,134 |
|
Restricted stock units (1)
|
4,690 |
|
|
— |
|
|
4,690 |
|
|
— |
|
Restricted stock awards (1)
|
250 |
|
|
— |
|
|
250 |
|
|
— |
|
Shares of Class V common stock (2)
|
— |
|
|
494 |
|
|
— |
|
|
494 |
|
| Total |
92,745 |
|
|
13,447 |
|
|
92,745 |
|
|
13,447 |
|
____________________
(1)Represents the number of instruments outstanding at the end of the period. Application of the treasury stock method would reduce this amount if they had a dilutive effect and were included in the computation of diluted net loss per share.
(2)Shares of Class V common stock at the end of the period, including shares tied to unvested Common Units, are considered potentially dilutive shares of Class A common stock under the application of the if-converted method.
|